Torsdag 6 November | 17:03:52 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-11-26 07:30 Kvartalsrapport 2026-Q3
2026-08-25 07:30 Kvartalsrapport 2026-Q2
2026-05-27 07:30 Kvartalsrapport 2026-Q1
2026-03-25 N/A Årsstämma
2026-02-25 07:00 Bokslutskommuniké 2025
2025-11-27 07:30 Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-28 - Kvartalsrapport 2025-Q1
2025-03-28 - X-dag ordinarie utdelning FLUO 0.00 DKK
2025-03-27 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-11-27 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-30 - Kvartalsrapport 2024-Q1
2024-03-21 - X-dag ordinarie utdelning FLUO 0.00 DKK
2024-03-20 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-29 - Kvartalsrapport 2023-Q3
2023-08-30 - Kvartalsrapport 2023-Q2
2023-05-31 - Kvartalsrapport 2023-Q1
2023-03-22 - X-dag ordinarie utdelning FLUO 0.00 DKK
2023-03-21 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-31 - Kvartalsrapport 2022-Q1
2022-05-19 - X-dag ordinarie utdelning FLUO 0.00 DKK
2022-05-18 - Årsstämma
2022-03-30 - Bokslutskommuniké 2021
2021-11-24 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-05-26 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning FLUO 0.00 DKK
2021-02-26 - Bokslutskommuniké 2020
2021-02-09 - Årsstämma
2020-11-20 - Kvartalsrapport 2020-Q3
2020-08-14 - Kvartalsrapport 2020-Q2
2020-05-27 - Kvartalsrapport 2020-Q1
2020-04-09 - X-dag ordinarie utdelning FLUO 0.00 DKK
2020-04-08 - Årsstämma
2020-02-28 - Bokslutskommuniké 2019
2019-11-29 - Kvartalsrapport 2019-Q3
2019-05-31 - Kvartalsrapport 2019-Q1

Beskrivning

LandDanmark
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
FluoGuide är ett danskt bolag verksamt inom medicinteknik. Bolaget affärsfokus återfinns inom forskning och utveckling av behandlingar mot olika cancerformer, med störst fokus på utveckling av produkter som vägleder vid kirurgiska ingrepp. Produkterna binder till sig cancercellerna som då lyser upp och är avsedda att användas för att med precision kunna ta bort skadliga tumörer i patientens vävnad.
2025-11-03 21:30:00

FluoGuide A/S announces that two of its shareholders, both of whom hold management and/or board positions in the Company, have entered into an agreement regarding a reorganisation of their shareholdings in the Company. There is no change in the ultimate ownership to the shares.

Background

Morten Albrechtsen who serves as Chief Executive Officer and Andreas Kjær who serves as Board Member of FluoGuide A/S and Chief Scientific Officer have agreed to restructure their ownership of shares in FluoGuide A/S so that their combined shareholding forthwith will be held by a jointly owned company. Prior to the reorganization Morten Albrechtsen ultimately owns 10.9% of the shares in FluoGuide A/S (1,488,610 shares) and Andreas Kjær ultimately owns 15.6% of the shares in FluoGuide (2,126,107 shares).

Transaction Details

Morten Albrechtsen’s wholly owned company will transfer all of its shares in FluoGuide A/S to Life Science ApS which before the transaction is wholly owned by Andreas Kjær. In consideration for this transfer, Morten Albrechtsen will receive shares in Life Science ApS reflecting the number of shares held by each of them in FluoGuide A/S. Life Science ApS will following the transaction own in aggregate 26.5% of the shares in FluoGuide A/S (3,614,717 shares) prior to registration the directed share issuance recently announced by FluoGuide A/S. Following the capital increase Life Science ApS will own 22.1% shares in FluoGuide A/S.

Governance Arrangements

The shareholders have agreed that all decisions in Life Science ApS shall be made unanimously. Both parties have equal influence over decisions affecting their combined shareholding in the Company. In the event of disagreements each party can require that Life Science ApS is liquidated.

Ultimate Ownership and Control

The transaction will not result in any change to the ultimate beneficial ownership of the shares in FluoGuide A/S. The economic interests of both shareholders remain unchanged following the reorganisation. Both individuals will continue in their respective roles within FluoGuide A/S.

Related Party Considerations

Given the positions held by both shareholders within the Company, this transaction has been disclosed in accordance with applicable related party requirements. The transaction is a private arrangement between the shareholders and does not involve any Company assets or resources. The board has been informed of the arrangement and the chairman of the board of directors notes that it does not affect the Company's operations or governance.

Impact on the Company

The reorganisation is a matter between the two shareholders and does not affect the Company's operations, strategy, or financial position.